Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for treating CEP290 associated disease

Compositions and methods for treating CEP290 associated disease

US Patent 11566263 · Granted Jan 31, 2023

Estimated economic value: $12,951,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crispr/CAS-related methods and compositions for treating primary open angle glau2025
CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated usher syndrome2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
TAL-Tet1 fusion proteins and methods of use thereof2024
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific g2024
Methods and compositions for treating cone-rod retinal dystrophy2023
Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided ge2023
Anti-betacellulin antibodies, fragments thereof, and multi-specific binding mole2022
Compositions and methods for treating CEP290-associated disease2022
Compositions and methods for treating CEP290-associated disease2022
Compositions and methods for treating CEP290-associated disease2022
CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amau2022